Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

IC Green

PreclinicalSmall molecule

IIndiana University

IC Green is one of 2 small molecule programs targeting Fluorescence. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

FluorescenceCompleted

FluorescencePreclinical

Completed

Competition

Competitive Landscape

5 competitors in Fluorescence

#DrugCompanyPhaseTrials

Humira

RRanbaxy Laboratories Limited

IC Green

IIndiana University

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fluorescence1 trial

Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging

Completed·IIndiana University·N/A·NCT01673022·430 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for IC Green. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — IC Green compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for IC Green. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Indiana University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: IIndiana University

Related News